Search

everythinglearnresearchcommunity

for

Search:↓

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

Newer GLP-1 drugs like semaglutide may cause hair loss.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.

Enhanced stem cells from the placenta can reduce fat buildup in eye tissue for Graves' disease.

Laser-assisted prostaglandin analogs improve hypopigmented scars safely, but more research is needed.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

Blocking androgen receptors early in life increases estrogen levels and reduces sexual motivation in male rats.

GLP-1 receptor agonists may help or harm hair health, needing more research.

Bimatoprost treats glaucoma and promotes hair growth, with potential for more medical uses.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

GLP-1 therapies, especially semaglutide and tirzepatide, may cause hair loss, particularly in women and with rapid weight loss.

Piperonylic acid may help hair growth and treat hair loss.

Androgen receptors in the brain affect metabolism and reproduction differently in males and females, and may help manage PCOS symptoms in females.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Analog 23 is a promising compound for prostate cancer treatment.

Upadacitinib effectively treats pyoderma gangrenosum.

The retinoid receptor antagonist effectively disrupts vitamin A-related development in embryos.

Neuroactive steroids affect cocaine's rewarding effects through the sigma1 receptor.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Breathing in newborn rats is affected differently by hormones based on their sex.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

More research is needed to understand if GLP-1 agonists affect hair health.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.